• Published

  Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy

  Bill, M., Aggerholm, A., Kjeldsen, E., Roug, A. S., Hokland, P. & Nederby, L., Mar 2019, In: British Journal of Haematology. 184, 5, p. 769-781 13 p.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

• Published

  The Nobel Prize for Medicine awarded for cancer therapy by inhibition of negative immune regulation

  Hokland, P., Hokland, M. & Cotter, F., Dec 2018, In: British Journal of Haematology. 183, 5, p. 698-700 3 p.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

• Published

  Systematic evaluation of signal-to-noise ratio in variant detection from single cell genome multiple displacement amplification and exome sequencing

  Simonsen, A. T., Hansen, M. C., Kjeldsen, E., Møller, P. L., Hindkjær, J. J., Hokland, P. & Aggerholm, A., 2018, In: BMC Genomics. 19, 1, 9 p., 681.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

• Published

  Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation

  Sørensen, C. D., Møller, B. K., Olesen, G., Hokland, P. & Hokland, M., Dec 2018, In: Bone Marrow Transplantation. 53, p. 1578-1582 5 p.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

• Published

  Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology

  Bill, M., van Kooten Niekerk, P. B., Woll, P. S., Herborg, L. L., Roug, A. S., Hokland, P. & Nederby, L., Apr 2018, In: Journal of Cellular and Molecular Medicine.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

• Published

  Cord-Blood Transplantation in Patients with Minimal Residual Disease

  Hourigan, C. S., Haferlach, T. & Hokland, P., 1 Dec 2016, In: The New England Journal of Medicine. 375, 22, p. 2204

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

• Published

  Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome

  Toft-Petersen, M., Nederby, L., Kjeldsen, E., Kerndrup, G. B., Brown, G. D., Hokland, P. & Stidsholt Roug, A., 9 Sep 2016, In: British Journal of Haematology.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

View all (234) »

• Exploring the diagnostic potential of imaging flow cytometry in myelodysplastic syndrome

  Project: Research

• Characterizing the clonal potential of CD34+CD38-CLEC12A+ cells in patients with myelofibrosis

  Project: Research

• EVOLUTION OF SUBCLONAL LEUKEMIC POPULATIONS DURING AND AFTER THERAPY IN MDS AND AML

  Project: Research

View all (16) »

• "Update on the CAR-T cell situation in Europe: expansion, but focus on selecting patients and CRISPR/Cas9 looming in the horizon." Host professor Pa-thai Yenchitsomanus.

  Peter Hokland (Lecturer)

  9 Feb 2018

  Activity: Talk or presentation types › Lecture and oral contribution

• "The minimal residual disease concept - from conception towards final clinical recognition" (Professor Danilo Perotti).

  Peter Hokland (Lecturer)

  25 Aug 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• "The minimal residual disease concept - from conception towards final clinical recognition" (Professor Lucy Godley).

  Peter Hokland (Lecturer)

  31 Aug 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• "The minimal residual disease concept - from conception towards final clinical recognition" (Professor Chris Hourigan).

  Peter Hokland (Lecturer)

  24 Aug 2017

  Activity: Talk or presentation types › Lecture and oral contribution

View all (140) »

• Honorary Prized of the Odd Fellow Order, Denmark

  Hokland, Peter (Recipient), 26 Apr 2009

  Prize: Prizes, scholarships, distinctions

View all (3) »

• Interview TV2 News at 10 p.m.

  Peter Hokland

  28/11/2018

  1 Media contribution

  Press/Media: Press / Media

• Interview P1 Orientering om Nobelpriser til Cancer Immunterapi

  Peter Hokland

  15/10/2018 → 15/11/2018

  2 Media contributions

  Press/Media: Press / Media

• https://dagensmedicin.dk/ny-analyse-banebrydende-kraeftmiddel-dyrt/

  Peter Hokland

  15/03/2018

  1 Media contribution

  Press/Media: Press / Media

• http://ugeskriftet.dk/nyhed/crispr-er-paa-vej-fra-mus-til-mennesker

  Peter Hokland

  08/01/2018

  1 Media contribution

  Press/Media: Press / Media

• Rødmossethed kan skyldes blodsygdomme – og være ligeså farligt som forhøjet kolesterol

  Peter Hokland

  13/08/2018

  1 Media contribution

  Press/Media: Press / Media

• Nu udrulles CRISPR/Cas gen korrektions teknikken til Danmark

  Peter Hokland

  03/10/2018

  1 Media contribution

  Press/Media: Press / Media

• Aldersgrænse på solarium vil give færre tilfælde af kræft, viser undersøgelse

  Peter Hokland

  09/10/2018

  1 Media contribution

  Press/Media: Press / Media

View all (41) »